FREE ELECTRONIC LIBRARY - Abstracts, online materials

Pages:     | 1 ||

«Clinical Commissioning policy: Amifampridine phosphate for the treatment of LambertEaston Myasthenic Syndrome Reference: NHS England: 16009/P ...»

-- [ Page 2 ] --

2) Is amifampridine phosphate cost effective in adult patients with confirmed Lambert-Eaton Myasthenic Syndrome?

No studies reporting on the cost-effectiveness of amifampridine phosphate were identified in the literature search.

The Cochrane Review (Keogh et al., 2011) provided a brief commentary on the costbenefit of 3, 4-DAP (base) versus 3, 4-DAP (phosphate). Using an average dose of 40mg daily, an average price for 3,4-DAP base of £1/tablet and an average price for 3,4-DAP phosphate of £2,017/100 tablets, the authors estimated a yearly cost per person of £730 for the base versus £29,448 for the phosphate formulation. This was

–  –  –

not a cost-effectiveness analysis, but rather a commentary on the increased pricing associated with the phosphate formulation.

6 Documents which have informed this Policy NHS England Clinical Commissioning Policy Statement: Amifampridine (Firdapse) for Lambert Easton Myasthenic Syndrome (LEMS). Published date: April 2013.

Reference : NHSCB/D04/PS/a 7 Date of Review This document will be reviewed when information is received which indicates that the policy requires revision.

–  –  –

References Flet L, Polard E, Guillard O et al. 3,4-Diaminopyridine safety in clinical practice: an observational,retrospective cohort study.. Journal of Neurology 2010;257:937-46 2010.

Keogh M, Sedehizadeh S, Maddison P.. Treatment for Lambert-Eaton myasthenic syndrome.. Cochrane Database Syst Rev. 2011;(2):CD003279.

NHS England Clinical Commissioning Policy Statement: Amifampridine (Firdapse) for Lambert Easton Myasthenic Syndrome (LEMS). Published date: April 2013.

Reference : NHSCB/D04/PS/a Sedehizadeh, Saam; Keogh, Michael; Maddison, Paul. The use of aminopyridines in

Pages:     | 1 ||

Similar works:

«Discover Your Self(s) in Puglia, Italy RHONDA LENAIR WITH September 24th 30th, 2016 and October 1st 7th, 2016 Join us for a nurturing, delicious and transformational week of discovery in Puglia with Rhonda Lenair, a prophet, luminary, medical intuitive and renowned healer who has been heralded as the ‘healer of addictions’ by tens of thousands of clients worldwide, for nearly three decades. As a medical intuitive, she has been compared over and over to the ‘Sleeping Prophet’ Edgar...»

«Washington State OSPI-Developed Health Assessment A Component of the Washington State Assessment Program Tobacco Times I don’t like it when my friend chews tobacco, it’s gross. Tobacco Times Health Assessment for Middle School Tobacco Times Building Office of Superintendent of Public Instruction P.O. Box 47200 Olympia, Washington 98504-7200 For more information about the contents of this document or to order more copies, please contact: Lisa Rakoz Program Supervisor, Health and Fitness...»

«D. Kemmerer, S.K. Wright / Journal of Neurolinguistics 15 (2002) 403±432 403 Journal of Neurolinguistics 15 (2002) 403±432 www.elsevier.com/locate/jneuroling Selective impairment of knowledge underlying unpre®xation: further evidence for the autonomy of grammatical semantics David Kemmerer a,b,1,*, Saundra K. Wright c a Department of Audiology and Speech Sciences, and Department of Psychological Sciences, 1353 Heavilon Hall, Purdue University, West Lafayette, IN 47907-1353, USA b Department...»

«DAILY COLLECTION OF MARITIME PRESS CLIPPINGS 2013 – 325 Number 325 *** COLLECTION OF MARITIME PRESS CLIPPINGS *** Thursday 21-11-2013 News reports received from readers and Internet News articles copied from various news sites. Willem Smetz, the dredge Master onboard the EDAX did see Abraham this week, as he turned 50 years whilst onboard the dredger, his workspace and surrounding was especially decorated for this occasion by the crew of the vessel A belated happy Birthday Willem ! Many more...»

<<  HOME   |    CONTACTS
2017 www.abstract.dislib.info - Abstracts, online materials

Materials of this site are available for review, all rights belong to their respective owners.
If you do not agree with the fact that your material is placed on this site, please, email us, we will within 1-2 business days delete him.